Literature DB >> 21619477

Improving clinical laboratory efficiency: a time-motion evaluation of the Abbott m2000 RealTime and Roche COBAS AmpliPrep/COBAS TaqMan PCR systems for the simultaneous quantitation of HIV-1 RNA and HCV RNA.

Alessandra Amendola1, Sabrina Coen, Stefano Belladonna, F Renato Pulvirenti, John M Clemens, M Rosaria Capobianchi.   

Abstract

BACKGROUND: Diagnostic laboratories need automation that facilitates efficient processing and workflow management to meet today's challenges for expanding services and reducing cost, yet maintaining the highest levels of quality.
METHODS: Processing efficiency of two commercially available automated systems for quantifying HIV-1 and HCV RNA, Abbott m2000 system and Roche COBAS Ampliprep/COBAS TaqMan 96 (docked) systems (CAP/CTM), was evaluated in a mid/high throughput workflow laboratory using a representative daily workload of 24 HCV and 72 HIV samples. Three test scenarios were evaluated: A) one run with four batches on the CAP/CTM system, B) two runs on the Abbott m2000 and C) one run using the Abbott m2000 maxCycle feature (maxCycle) for co-processing these assays. Cycle times for processing, throughput and hands-on time were evaluated.
RESULTS: Overall processing cycle time was 10.3, 9.1 and 7.6 h for Scenarios A), B) and C), respectively. Total hands-on time for each scenario was, in order, 100.0 (A), 90.3 (B) and 61.4 min (C).
CONCLUSIONS: The interface of an automated analyzer to the laboratory workflow, notably system set up for samples and reagents and clean up functions, are as important as the automation capability of the analyzer for the overall impact to processing efficiency and operator hands-on time.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21619477     DOI: 10.1515/CCLM.2011.625

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  6 in total

1.  Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections.

Authors:  Sam Ratnam; Dan Jang; Jodi Gilchrist; Marek Smieja; Andre Poirier; Todd Hatchette; Jean-Frederic Flandin; Max Chernesky
Journal:  J Clin Microbiol       Date:  2014-04-16       Impact factor: 5.948

2.  Development of a contemporary globally diverse HIV viral panel by the EQAPOL program.

Authors:  Ana M Sanchez; C Todd DeMarco; Bhavna Hora; Sarah Keinonen; Yue Chen; Christie Brinkley; Mars Stone; Leslie Tobler; Sheila Keating; Marco Schito; Michael P Busch; Feng Gao; Thomas N Denny
Journal:  J Immunol Methods       Date:  2014-01-19       Impact factor: 2.303

3.  Evaluation of quantification of HIV-1 RNA viral load in plasma and dried blood spots by use of the semiautomated Cobas Amplicor assay and the fully automated Cobas Ampliprep/TaqMan assay, version 2.0, in Kisumu, Kenya.

Authors:  Kenneth N Ouma; Sridhar V Basavaraju; Jully A Okonji; John Williamson; Timothy K Thomas; Lisa A Mills; John N Nkengasong; Clement Zeh
Journal:  J Clin Microbiol       Date:  2013-02-06       Impact factor: 5.948

4.  Impact of the New Abbott mPLUS feature on clinical laboratory efficiencies of abbott RealTime assays for detection of HIV-1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeae.

Authors:  Danijela Lucic; Sara Jones; Russ Wiesneth; Cathy Barry; Erika Webb; Larissa Belova; Peggy Dolan; Shiaolan Ho; Klara Abravaya; Gavin Cloherty
Journal:  J Clin Microbiol       Date:  2013-10-02       Impact factor: 5.948

5.  Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses.

Authors:  Mt Cabezas-Fernandez; Mi Cabeza-Barrera
Journal:  Open Virol J       Date:  2012-11-30

6.  Acute Infections, Cost per Infection and Turnaround Time in Three United States Hospital Laboratories Using Fourth-Generation Antigen-Antibody Human Immunodeficiency Virus Immunoassays.

Authors:  Laura G Wesolowski; Muazzam Nasrullah; Robert W Coombs; Eric Rosenberg; Steven F Ethridge; Angela B Hutchinson; Joan Dragavon; Jennifer Rychert; Frederick S Nolte; James E Madory; Barbara G Werner
Journal:  Open Forum Infect Dis       Date:  2015-12-09       Impact factor: 3.835

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.